Penicillins, cephalosporins, other β-lactam antibiotics, and tetracyclines

Cannon, 1995, 1 Ôsterblad, 1995, Anti-microbial and mercury resistance in aerobic gramnegative bacilli in fecal flora among persons with and without dental amalgam fillings, Antimicrob Agents Chemother, 39, 2499, 10.1128/AAC.39.11.2499 Stone, 1992, On the evolution of functional secondary metabolites (natural products), Mol Microbiol, 6, 29, 10.1111/j.1365-2958.1992.tb00834.x Ghuysen, 1991, Serine beta-lactamases and penicillin-binding proteins, Ann Rev Microbiol, 45, 37, 10.1146/annurev.mi.45.100191.000345 Joris, 1988, The activesite-serine penicillin-recognizing enzymes as membranes of the Streptomyces R61 DD-peptidase family, Biochem J, 250, 313, 10.1042/bj2500313 Moulder, 1993, Why is Chlamydia sensitive to penicillin in the absence of peptidoglycan?, Infect Agents Dis, 2, 87 Goldstein, 1995, Resistance to ceftriaxone and other beta-lactams in bacteria isolated in the community, Antimicrob Agents Chemother, 39, 2516, 10.1128/AAC.39.11.2516 Böhmer, 1990, Pivampicillin (Pondocillin) og pivmecillinam (Selexid) kan gi karnitinmangel, Tidsskr Nor Laegeforen, 110, 2090 Abrahamsson, 1994, Impaired ketogenesis in carnitine depletion caused by short-term administration of pivalic acid prodrug, Biochem Med Metab Biol, 52, 18, 10.1006/bmmb.1994.1028 Abrahamsson, 1995, Effect of short-term treatment with pivalic acid containing antibiotics on serum carnitine concentration—risk irrespective of age, Biochem Mol Med, 55, 77, 10.1006/bmme.1995.1036 Abrahamsson, 1995, Transient reduction of human left ventricular mass in carnitine depletion induced by antibiotics containing pivalic acid, Br Heart J, 74, 656, 10.1136/hrt.74.6.656 Fujii, 1994, Effect of cefditoren pivoxil on carnitine metabolism in pediatric patients, Jpn J Antibiot, 46, 926 Shimizu, 1993, Carnitine status and safety after administration of S-1108, a new oral cephem, to patients, Antimicrob Agents Chemother, 37, 1043, 10.1128/AAC.37.5.1043 Nakashima, 1992, Phase I clinical studies of S-1108: safety and pharmacokinetics in a multiple-administration study with special emphasis on the influence on carnitine body stores, Antimicrob Agents Chemother, 36, 762, 10.1128/AAC.36.4.762 Ito, 1995, Alteration of ammonia and carnitine levels in short-term treatment with pivalic acid-containing prodrug, Tohoku J Exp Med., 175, 43, 10.1620/tjem.175.43 Abrahamsson, 1996, Carnitine depletion in man Rose, 1992, Carnitine deficiency associated with long-term pivampicillin treatment: the effect of a replacement therapy regime, Postgrad Med J, 68, 932, 10.1136/pgmj.68.805.932 Watson, 1988, Clinical pharmacokinetics of enzyme inhibition in antimicrobial chemotherapy, Clin Pharmacokinet, 15, 133, 10.2165/00003088-198815030-00001 Neu, 1978, Clavulanic acid, a novel inhibitor of beta-lactamases, Antimicrob Agents Chemother, 14, 650, 10.1128/AAC.14.5.650 Reddy, 1989, Amoxicillin—clavulanate potassium-associated cholestasis, Gastroenterology, 96, 1135, 10.1016/0016-5085(89)91633-8 Schneider, 1989, Cholestatic hepatitis after therapy with amoxicillin/clavulanate potassium, New York State J Med, 89, 355 Verhamme, 1989, Cholestatic hepatitis due to an amoxycillin/clavulanic acid preparation, J Hepatol, 9, 260, 10.1016/0168-8278(89)90061-5 Dowsett, 1989, Amoxycillin/clavulanic acid (Augmentin)-induced intrahepatic cholestasis, Dig Dis Sci, 34, 1290, 10.1007/BF01537281 Stricker, 1989, Cholestatic hepatitis due to antibacterial combination of amoxicillin and clavulanic acid (Augmentin), Dig Dis Sci, 34, 1576, 10.1007/BF01537113 Michielsen, 1990, Amoxycillin/clavulanic acid induced cholestasis, J Hepatol, 11, 392, 10.1016/0168-8278(90)90230-O Pelletier, 1990, Hépatite cholestatique probablement due à l'association d'amoxicilline et d'acide clavulanique, Gastroenterol Clin Biol, 14, 601 Wong, 1991, Augmentin-induced jaundice, Med J Aust, 154, 698, 10.5694/j.1326-5377.1991.tb121267.x Alexander, 1991, Intrahepatic cholestasis induced by amoxicillin/clavulanic acid (Augmentin): a report on two cases, Acta Clin Belg, 46, 327, 10.1080/17843286.1991.11718184 Smith, 1991, Jaundice associated with amoxycillin—clavulanate potassium therapy, Eur J Gastroenterol Hepatol, 3, 95 Larrey, 1992, Hepatatis associated with amoxycillin—clavulanic acid: combination report of 15 cases, Gut, 33, 368, 10.1136/gut.33.3.368 Hebbard, 1992, Augmentin-induced jaundice with a fatal outcome, Med J Aust, 156, 285, 10.5694/j.1326-5377.1992.tb139752.x Hautekeete, 1995, Liver injury related to amoxycillin—clavulanic acid: interlobular bile-duct lesions and extrahepatic manifestations, J Hepatol, 22, 71, 10.1016/0168-8278(95)80262-2 Benichou, 1990, Criteria of drug-induced liver disorders: report of an international consensus meeting, J Hepatol, 11, 272, 10.1016/0168-8278(90)90124-A Westphal, 1994, Hepatic side-effects of antibiotics, J Antimicrob Chemother, 33, 387, 10.1093/jac/33.3.387 De Sarro, 1993, Quinolones potentiate cefazolin-induced seizures in DBA/2 mice, Antimicrob Agents Chemother, 37, 1497, 10.1128/AAC.37.7.1497 De Sarro, 1995, Relationship between structure and convulsant properties of some beta-lactam antibiotics following intracerebroventricular microinjection in rats, Antimicrob Agents Chemother, 39, 232, 10.1128/AAC.39.1.232 Kamei, 1983, Epileptogenic activity of cephalosporins in rats and their structure-activity relationship, Epilepsia, 24, 431, 10.1111/j.1528-1157.1983.tb04913.x Van Gelder, 1983, Feline generalized penicillin epilepsy: changes of glutamic acid and taurine parallel the progressive increase in excitability of the cortex, Epilepsia, 24, 200, 10.1111/j.1528-1157.1983.tb04880.x Karbwang, 1994, Clinical application of mefloquine pharmacokinetics in the treatment of P. falciparum malaria, Fundam Clin Pharmacol, 8, 491, 10.1111/j.1472-8206.1994.tb00830.x Bunnag, 1992, Clinical trials of mefloquine with tetracycline, Southeast Asian J Trop Med Public Health, 23, 377 Bolt, 1994, Interactions between clinically used drugs and oral contraceptives, Environ Health Perspect, 102, 35, 10.1289/ehp.94102s935 Henkin, 1976, Taste in man, 468 Henkin, 1993, Evaluation and treatment of human olfactory disfunction, Vol. 2, 1 Bleasal, 1990, Anosmia after doxycycline use, Med J Aust, 152, 440, 10.5694/j.1326-5377.1990.tb125275.x Abbott Laboratories. Data on file. Wallace, 1993, Drug intolerance to high-dose clarithromycin among elderly patients, Diagn Microbiol Infect Dis, 16, 215, 10.1016/0732-8893(93)90112-K Tompsett, 1967, Pseudoanaphylactic reactions to procaine penicillin G, Arch Intern Med, 120, 565, 10.1001/archinte.1967.00300040049008 Henkin, 1994, Drug-induced taste and smell disorders. Incidence, mechanisms and management related primarily to treatment of sensory receptor dysfunction, Drug Safety, 11, 318, 10.2165/00002018-199411050-00004 Jaffe, 1970, Ampicillin rashes, Lancet, i, 241 Bryskier, 1995, C-3′ quaternary ammonium cephems, a new wave of cephalosporins, J Clin Microbiol Infect, 1, 1, 10.1111/j.1469-0691.1995.tb00015.x Bryskier, 1994, Parenteral cephalosporin classification, Expert Opin Invest Drugs, 3, 145, 10.1517/13543784.3.2.145 King, 1995, The composition in vitro activity of FK-037 (cefoselis), a new broad-spectrum cephalosporin, J Clin Microbiol Infect, 1, 13, 10.1111/j.1469-0691.1995.tb00018.x